Cargando…

Prognostic factors for post-recurrence survival among patients with locally advanced cervical cancer who underwent definitive concurrent chemoradiation

BACKGROUND: The prognostic factors affecting post-recurrence survival (PRS) in patients with locally advanced cervical cancer (LACC) who receive concurrent chemoradiation (CCRT) are not well established. This study aimed to assess the prognostic factors for PRS in patients with recurrent LACC who un...

Descripción completa

Detalles Bibliográficos
Autores principales:	Thongkhao, Pitchaya, Janmunee, Narumon, Tangkananan, Aimwarin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Via Medica 2022
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9521700/ https://www.ncbi.nlm.nih.gov/pubmed/36196420 http://dx.doi.org/10.5603/RPOR.a2022.0078

Ejemplares similares

Survival impact of additional chemotherapy after adjuvant concurrent chemoradiation in patients with early cervical cancer who underwent radical hysterectomy
por: Kim, Se Ik, et al.
Publicado: (2021)

Effect of Waiting Time from Pathological Diagnosis to Definitive Concurrent Chemoradiation for Cervical Cancer on Overall Survival
por: Noh, Kyoung Won, et al.
Publicado: (2022)

Impact of hematologic toxicities during concurrent chemoradiation for cervical cancer
por: Shi, Feiya, et al.
Publicado: (2022)

A randomized controlled trial comparing concurrent chemoradiation versus concurrent chemoradiation followed by adjuvant chemotherapy in locally advanced cervical cancer patients: ACTLACC trial
por: Tangjitgamol, Siriwan, et al.
Publicado: (2019)

Clinical Outcome in Definitive Concurrent Chemoradiation With Weekly Paclitaxel and Carboplatin for Locally Advanced Esophageal and Junctional Cancer
por: Noronha, Vanita, et al.
Publicado: (2016)

Age-Adjusted Charlson Comorbidity Index Scores as Predictor of Survival in Colorectal Cancer Patients Who Underwent Surgical Resection and Chemoradiation
por: Wu, Chin-Chia, et al.
Publicado: (2015)

Treatment Outcome and Prognosis Factors of FIGO 2018 Stage III Cervical Cancer Patients Treated with Definitive Concurrent Chemoradiation in Vietnam
por: Phung, Huyen Thi, et al.
Publicado: (2021)

Prognostic Significance of Sarcopenia With Inflammation in Patients With Head and Neck Cancer Who Underwent Definitive Chemoradiotherapy
por: Cho, Yeona, et al.
Publicado: (2018)

Concurrent Chemoradiation for Vaginal Cancer
por: Miyamoto, David T., et al.
Publicado: (2013)

Integration of Consolidation Chemotherapy After Concurrent Chemoradiation in the Treatment of Locally Advanced Uterine Cervical Cancer
por: Haritha, V. S., et al.
Publicado: (2022)

A prospective comparative study between concurrent chemoradiation with brachytherapy boost with concurrent chemoradiation alone in locally advanced cancer esophagus
por: Tudu, Rajanigandha
Publicado: (2020)

Factors predictive of parametrial boost in patients with cervical cancer treated with definitive chemoradiation
por: Jamora, Kurl E., et al.
Publicado: (2022)

Concurrent definitive chemoradiation incorporating intensity-modulated radiotherapy followed by adjuvant chemotherapy in high risk locally advanced cervical squamous cancer: a phase II study
por: Zhang, Gong-yi, et al.
Publicado: (2022)

A Case of Recurrent Esophageal Cancer Treated with Concurrent Chemoradiation Therapy in Pregnancy
por: Yamada, Kaori, et al.
Publicado: (2018)

Comparison of platinum monotherapy with concurrent chemoradiation therapy versus platinum-based dual drug therapy with concurrent chemoradiation therapy for locally advanced cervical cancer: a systematic review and meta-analysis
por: Deng, Ting, et al.
Publicado: (2022)

Long-term patient-reported distress in locally advanced cervical cancer patients treated with definitive chemoradiation
por: Conway, Jessica L., et al.
Publicado: (2020)

Dysfunction of apoptosis and autophagy correlates with local recurrence in esophageal squamous cell carcinoma after definitive chemoradiation
por: Qiu, Hu, et al.
Publicado: (2021)

Variable uterine uptake of FDG in adenomyosis during concurrent chemoradiation therapy for cervical cancer
por: Yu, Jeong Il, et al.
Publicado: (2011)

Concurrent Chemoradiation for Mediastinal Oligometastases From Cervical Cancer: A Potentially Curative Treatment
por: Bonilla, Carlos E, et al.
Publicado: (2020)

The outcomes and prognostic factors of patients who underwent reoperation for persistent/recurrent papillary thyroid carcinoma
por: Sun, Wenyu, et al.
Publicado: (2022)

Concurrent chemoradiation with carboplatin for locally advanced cervical cancer at high-risk for developing cisplatin-induced renal dysfunction
por: Cetina, Lucely, et al.
Publicado: (2007)

Is extended-field concurrent chemoradiation an option for radiologic negative paraaortic lymph node, locally advanced cervical cancer?
por: Asiri, Mushabbab Al, et al.
Publicado: (2014)

Concurrent chemoradiation versus radiotherapy alone for the treatment of locally advanced cervical cancer in a low-resource setting
por: Pereira, Elena, et al.
Publicado: (2016)

The biochemical recurrence-free rate in patients who underwent prostate low-dose-rate brachytherapy, using two different definitions
por: Tanaka, Nobumichi, et al.
Publicado: (2014)

Prognostic factors in patients with thymoma who underwent surgery
por: Jiang, Yu-Gang, et al.
Publicado: (2023)

The comparative study for survival outcome of locally advanced cervical cancer treated by neoadjuvant arterial interventional chemotherapy or intravenous chemotherapy followed by surgery or concurrent chemoradiation
por: Sun, Yi, et al.
Publicado: (2022)

Prognostic factors and survival of patients with brain metastasis from breast cancer who underwent craniotomy
por: Leone, José Pablo, et al.
Publicado: (2015)

Newly Developed Sarcopenia as a Prognostic Factor for Survival in Patients who Underwent Liver Transplantation
por: Jeon, Ja Young, et al.
Publicado: (2015)

Clinical Responses and Prognostic Indicators of Concurrent Chemoradiation for Non-small Cell Lung Cancer
por: Lee, Dong-Soo, et al.
Publicado: (2011)

HIV and Early Treatment Outcomes Among Women With Cervical Cancer Treated With Concurrent Chemoradiation in Tanzania
por: Mrema, Alita Steven, et al.
Publicado: (2023)

Long-term survival after concurrent chemoradiation therapy for esophageal cancer with tracheal invasion
por: Cho, Joon Hyun, et al.
Publicado: (2015)

Definitive chemoradiation in patients with inoperable oesophageal carcinoma
por: Crosby, T D L, et al.
Publicado: (2004)

Role of concurrent chemoradiation on locally advanced unresectable adenoid cystic carcinoma
por: Ha, Hyerim, et al.
Publicado: (2021)

Factors Predictive of Protracted Course of Radiation Therapy in Patients Treated with Definitive Chemoradiation for Cervical Cancer
por: Zaki, Mark, et al.
Publicado: (2016)

Health-related quality of life and late morbidity in concurrent chemoradiation and radiotherapy alone in patients with locally advanced cervical carcinoma
por: Berveling, Maaike J., et al.
Publicado: (2011)

Clinical Impact of Pelvic Lymph Node Status in Locally Advanced Cervical Cancer Patients Treated by Concurrent Chemoradiation Therapy
por: Katanyoo, Kanyarat, et al.
Publicado: (2021)

Definitive Chemoradiation Associated with Improved Survival Outcomes in Patients with Synchronous Oligometastatic Esophageal Cancer
por: Matoska, Thomas, et al.
Publicado: (2023)

Should salvage surgery be considered for local recurrence after definitive chemoradiation in locally advanced non-small cell lung cancer?
por: Schreiner, Waldemar, et al.
Publicado: (2016)

Durable Local Control Following Concurrent Hypofractionated Chemoradiation for a Massive Inflammatory Breast Cancer Chest Wall Recurrence
por: Dyer, Brandon A, et al.
Publicado: (2017)

Rapidly Extensive Recurrence of Esophageal Neuroendocrine Carcinoma After Complete Pathologic Response to Definitive Chemoradiation
por: Wang, Maxwell M., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_dtqi8imerflmia59p59qqces2a